Vaxart Can't Ditch Claims Co. Lied To Investors About Vaccine
By Dorothy Atkins · December 22, 2021, 8:01 PM EST
A California federal judge kept alive a proposed securities class action Wednesday claiming the biotechnology company Vaxart pumped up its stock price with deceptive headlines about a COVID-19 vaccine, but tossed...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login